USPTO 2015–2025 USPTO PatentsView Foreign Corporation

LDR Medical

USPTO PatentsView assignee record - 75 granted patents across 4 technology areas, recorded in grant years 2015–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61F (Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive Device).

RSS updates for this company

The verdict

According to USPTO PatentsView, LDR ranks #4,673 of 49,997 tracked US assignees by granted-patent volume, with 75 patents across 4 technology areas.

#4,673
of 49,997 US assignees by volume
47th percentile
by Innovation Score (34.2/100)
17.0
avg claims per patent
-81%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R4673 · Foreign Corporation #4,673 · 75 grants

GRANTS-SMALL · TOP-DECILE · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-RICH · TYPE-FRNCORP · VEL-DROP · BOOK-FULL

  • GRANTS-SMALL 75 grants
  • TOP-DECILE #4,673/49,997
  • PHOTO-FINISH Hussmann
  • CPC-NARROW A61F · 4 areas
  • INNOV-THIN 34.2/100
  • CLAIMS-RICH 17.0 claims/avg
  • TYPE-FRNCORP Foreign Corp
  • VEL-DROP -81% vel
  • BOOK-FULL 10/10 fields

Nearest grant-volume peer: Hussmann Corporation (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

Innovation-score neighbourhood around LDR

Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.

score

What this shows LDR's Innovation Score is 34.2/100 (47th percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Source USPTO PatentsView, PlainPatent Innovation Score As of 2015–2025

Where LDR's grants concentrate

LDR Medical is a focused PatentsView assignee: 4 CPC subclasses with 74.7% of grants classified under A61F (Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive Device). Peak complete grant year is 2017 (17 grants) versus a trough of 2 in 2022. By volume, LDR sits between Hussmann Corporation and Oren Technologies, LLC.

LDR's three-year grant acceleration

From 2019–2021 to 2022–2024, LDR Medical moved from 20 to 6 grants (0.30x the prior three-year total, a multiple, not a CAGR). See the growth leaderboard.

Who files at LDR's volume?

Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀

patents

What this shows LDR holds 75 patents at rank #4,673, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Source USPTO PatentsView, granted utility patents As of 2015–2025

Companies ranked near LDR

By rank, the assignees closest to #4,673 in granted patent volume.

Leaders in A61F (Filters Implantable Into Blood Vessels)

Other assignees with the most granted patents in LDR's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for LDR, neither rank-band nor same-CPC leaders (those blocks stay above).

LDR's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

34 47th percentile higher than 47% of 49,997 US assignees

This assignee 0 100 every tracked assignee, bucketed by value

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

05101520 2015201620172018201920202022202320242025 1
USPTO utility patent grants by year · 2015–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table
LDR Medical patent grants by year, 2015–2025
Year Patents Granted Share of Period
2015 9 12.0%
2016 11 14.7%
2017 17 22.7%
2018 11 14.7%
2019 14 18.7%
2020 6 8.0%
2022 2 2.7%
2023 2 2.7%
2024 2 2.7%
2025partial year 1 1.3%

Where it ranks

Overall rank by patents

#4,673

of 49,997 tracked assignees

Innovation Score

34.2 out of 100

View all rankings →

Data Source

USPTO PatentsView, US granted patents 2015–2025

How is Innovation Score calculated?

What to do with this data

LDR Medical's patent record in context - here's where to go next.

  • LDR Medical's lead technology class is A61F (Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive Device), 74.7% of its portfolio - see every assignee active in that class. Explore A61F
  • Ranked #4,673 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
  • Compare LDR Medical against Hussmann Corporation, an assignee filing at a similar volume. Compare portfolios
  • Innovation Score of 34.2/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.